Thrombotic Events Associated to Aspirin Therapy
Open Access
- 24 November 2011
- journal article
- review article
- Published by Hindawi Limited in Thrombosis
- Vol. 2012, 1-5
Abstract
Acetyl salicylic acid (ASA) is widely used in clinical practice. Previous studies done in rats showed unexpected thrombotic potencies of this drug used at ultra-low doses. This review is the first report in which the effects of a wide range of ASA concentration on a microvessel model of laser-induced thrombus formation and Induced Hemorrhagic Time in animals were largely studied.Keywords
This publication has 17 references indexed in Scilit:
- Reverse Effect of Aspirin: Is the Prothrombotic Effect after Aspirin Discontinuation Mediated by Cyclooxygenase 2 Inhibition?Pathophysiology of Haemostasis and Thrombosis, 2007
- A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery diseaseEuropean Heart Journal, 2006
- Low‐dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta‐analysisJournal of Internal Medicine, 2005
- Coronary syndromes following aspirin withdrawalJACC, 2005
- Discontinuation of Nonsteroidal Anti-inflammatory Drug Therapy and Risk of Acute Myocardial InfarctionArchives of internal medicine (1960), 2004
- Aspirin Withdrawal and Acute Lower Limb IschemiaAnesthesia & Analgesia, 2004
- Thromboembolic Complications Several Days After a Single-Dose Administration of AspirinThrombosis Research, 1998
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell, 1995
- Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouseCell, 1995
- Effects of Aspirin on Embolization in an Arterial Model of Laser-Induced Thrombus FormationPathophysiology of Haemostasis and Thrombosis, 1993